Italian glass manufacturer Bormioli Pharma has completed the acquisition of GCL Pharma.
GCL Pharma is an Italian company that specialises in pharma closures.
Bormioli Pharma said: “It’s a new and relevant step in the right direction along our growth path, allowing us to serve the global pharma industry with more energy and renewed resources.”
The pharmaceutical glassmaker issued a binding offer of €8.9 million last month for GCL, which is a subsidiary of the Guala Closures Group.
GCL specialises in the production of plastic, rubber and aluminium closures for pharmaceutical applications.
In 2019 GCL Pharma recorded a turnover of approximately €8 million. The company’s main premises and production plant are located in Vasto, Chieti, Italy.
07.05.2020, Bormioli Pharma
Notícias sobre o material do site é copyright e pertence à empresa ou ao seu fornecedor de terceiros notícia, e todos os direitos reservados. Qualquer usuário que acessa esse material poderá fazê-lo apenas para seu próprio uso pessoal, bem como a utilização desse material é de risco exclusivo do Utilizador. A redistribuição ou exploração comercial de material tal notícia é expressamente proibida. Se tal notícia material é fornecido por um terceiro, cada utilizador concorda em observar e estar vinculado aos termos específicos de utilização aplicáveis a material notícia. Nós não representamos nem endossamos a precisão ou confiabilidade de qualquer informação contida em qualquer notícia ou sites externos referidos na notícia.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.